Drug fools immune system to fight allergy

Sep 29, 2006

A Swiss company is testing a hay fever drug that tricks the human immune system into acting as if it has been exposed to an infectious agent found in dirt.

Cytos Biotechnology has tested CYT 003-QbG10 on 10 people with hay fever and has found that their sensitivity to grass pollen is 1 percent after treatment to what it was before, New Scientist magazine reports. So far, the subjects have been free of hay fever for eight months.

A previous study found that people who are sensitive to dust mites have remained free of symptoms for at least a year.

The drug mimics the effect of exposure to mycobacteria, which somehow reboots the immune system, New Scientist said.

Copyright 2006 by United Press International

Explore further: Xtoro approved for swimmer's ear

add to favorites email to friend print save as pdf

Related Stories

Crystalizing the foundations of better antihistamines

Nov 21, 2011

Researchers in Japan have solved the structure of a complex between the antihistamine drug doxepin and its target receptor histamine H1 receptor (H1R)1. Led by So Iwata of Kyoto University and the RIKEN Systems ...

Change in drug payment rule may trigger headaches

Nov 15, 2010

(AP) -- A headache awaits people who use those tax-free health spending accounts to pay for over-the-counter allergy relievers, heartburn blockers and other drugstore remedies. Starting next year, you'll need a prescription ...

Pollen Folds Like Origami

Apr 20, 2010

For those of us with allergies, springtime pollen is an invisible nuisance. But under the high-powered microscopes of Eleni Katifori, a biophysicist at Rockefeller University in New York, the grains of plant ...

Recommended for you

Xtoro approved for swimmer's ear

13 hours ago

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

14 hours ago

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.